qNIV Vaccine with Matrix-M Adjuvant

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Study to Evaluate the Safety and Immunogenicity of COVID-19 and Influenza Combination VaccineNCT05519839NovavaxPhase 2Completed2023-07-25Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.